Bristol-Myers Squibb

Overview

Bristol-Myers Squibb (BMS) is a prominent player in the pharmaceutical manufacturing industry, founded in 1887 and based in the United States. The company is engaged in various initiatives aimed at enhancing patient care and advancing immunotherapy. One notable project is the National Immuno-Oncology Clinical Network, a collaboration with Clatterbridge Cancer Centre, which seeks to improve the management of immunotherapy in the UK by fostering a structured network of clinical leaders. Additionally, BMS has published work focusing on patient-centric healthcare reform in Australia, emphasizing the importance of integrating patient values and preferences into healthcare decision-making. Their whitepapers advocate for enhanced consumer engagement in the lifecycle of medicines, including design, approval, and post-marketing review processes. BMS's commitment to patient centricity is reflected in its partnerships with government and healthcare organizations to support a more equitable and efficient healthcare system. The company employs over 10,000 individuals and reported significant revenue, underscoring its substantial role in the pharmaceutical sector.

Industry